a study of kanyalohadi vati and hingvadi vati in Painfull menses

A RANDOMIZED CLINICAL STUDY OF KANYALOHADI VATI AND HINGVADI VATI IN THE MANAGEMENT OF KASHTARTAVA WITH SPECIAL REFERENCE TO PRIMARY DYSMENORRHOEA

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/04/018769

Enrollment

100

Registered

2019-04-24

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N944- Primary dysmenorrhea

Interventions

Intervention1: kanyalohadi vati: Kanyalohadi Vati (Kanyasaar,Kasees, Twaka, Ela, Shunthi,Gulkand)500 mg B.D. with lukewarm water as anupana for 60 days Control Intervention1: Hingvadi Vati: Hingvadi

Eligibility

Inclusion criteria

Inclusion criteria: Patients coming with chief complaint of Kashtartava with scanty or average amount of menses. Patints with history of using any type of analgesics during menses. Patients suffering with Kashtartava since more than 2 consecutive cycles.

Exclusion criteria

Exclusion criteria: Patient suffering from secondary dysmenorrhoea. Patient suffering from sexually transmitted infections. Patient suffering from systemic diseases. Patient having organic pathology of uterus and adnexa e.g. Fibroid uterus, carcinoma of endometrium etc. Patients having Dysfunctional Uterine Bleeding.

Design outcomes

Primary

Measure	Time frame
Improvement in Pain intensity, Duration, Nature of pain, Menstrual blood flow duration and Changes in associated symptoms Timepoint: 60 days	—

Secondary

Measure	Time frame
Relief in Primary dysmenorrhoeaTimepoint: 60 days	—

Countries

India

Contacts

Public ContactSONIKA PAL

NATIONAL INSTITUTE OF AYURVEDA

baruhunt@gmail.com9492047131

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026